Login / Signup

Lipid Nanoparticles for Enhancing the Physicochemical Stability and Topical Skin Delivery of Orobol.

Min-Hwan KimYae-Eun JeonSoobeen KangJae-Young LeeKi Won LeeKi-Taek KimDae-Duk Kim
Published in: Pharmaceutics (2020)
Orobol is one of the major soy isoflavones, and has been reported to have various pharmacological activities, including an anti-skin-aging effect. However, since it has low solubility in water and physicochemical instability, the formulation of orobol for delivery into the dermal layer of the skin could be challenging. The objective of this study was to prepare lipid nanoparticles formulations of orobol to enhance its stability as well as its deposition into the skin. Formulations of orobol-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) were characterized in terms of their mean particle size, entrapment efficiency, and morphology. The nano-sized spherical NLCs formulations maintained the stability of orobol for up to 28 days. Moreover, the NLCs formulation significantly increased the in vitro deposition of orobol into both Strat-M membranes and human cadaver skin compared with the other formulations. Additionally, the NLCs formulation did not cause significant skin irritation in clinical study. These results demonstrate that a shea butter-based NLC formulation could be a promising and safe carrier system for improving the stability of orobol and enhancing its topical skin delivery.
Keyphrases
  • wound healing
  • soft tissue
  • drug delivery
  • fatty acid
  • clinical trial
  • cancer therapy
  • walled carbon nanotubes
  • oxide nanoparticles